Erythema migrans
Related Experiment Video
Updated: Jul 5, 2026

Precision Implementation of Minimal Erythema Dose (MED) Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Patricia Dandache1, Robert B Nadelman
1Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY 10595, USA.
Abstract:
Erythema migrans (EM) is the most common objective manifestation of Lyme disease, accounting for about 90% of cases. Establishing the diagnosis of EM is important because appropriate treatment with oral antibiotics at an early stage of infection with Borrelia burgdorferi results in excellent outcomes. This article includes a discussion of the epidemiology of EM and its clinical, differential, and laboratory diagnosis. The treatment of EM and the prevention of Lyme disease are also discussed.
Related Concept Videos
Endocarditis II: Clinical Features of Infective Endocarditis
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Acute Inflammation II: Cellular Phase
Migration
Rocky Mountain Spotted Fever
Inflammatory Response I: Vascular and Cellular
